Selena Gomez’s Lupus Flare Up at AMA’s

Selena Gomez took to the American Music Awards (AMAs) stage for the first time in two years on Sunday night to perform two new tracks, ‘Lose You To Love Me’ and ‘Look At Her Now’.

However, the 27-year-old singer was criticised for her vocals during her set with some people claiming she sounded “shaky” and “off-key”.

Selena’s fans rushed to defend her, saying she reportedly had a lupus flare up and an anxiety attack before going on stage, which was why it “wasn’t her best performance”.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Immupharma Plc

    More articles like this

    Immupharma Plc

    What the Coronavirus Means for People with Lupus

    In recent weeks, a new type of virus widely known as the coronavirus (sometimes called COVID-19) has been spreading around the world. There have been a number of stories in the news of people getting sick

    Immupharma Plc

    Toni Braxton Opens Up About Living with Lupus

    When autoimmune disease strikes, entire families are affected. Toni Braxton, 52, was diagnosed with lupus in 2008. At the time, she had to conjure up a way to carefully explain to her young children why she’d been in

    Immupharma Plc

    Where Are the Manuals for Life?

    People tease about how there are no manuals for rearing kids. Well, there is no manual on how to navigate an illness like lupus, either. Everyone is simply winging it and hoping they are making the

    Immupharma Plc

    How Lupus Affects the Aging Process

    Lupus (systemic lupus erythematosus or SLE) can influence your normal aging process, and your normal aging process likewise can have an effect on your lupus symptoms and your quality of life. What should you know? You probably know that

    Immupharma Plc

    What is lupus?

    Lupus is an autoimmune rheumatic condition that causes the immune system to start working against different parts of the body, including joints and organ systems. It tends to cause increased inflammation in the body.  It’s an

    Immupharma Plc

    ImmuPharma Positive and proactive progress with Avion

    ImmuPharma PLC (LON:IMM), a specialist drug discovery and development company, has today announced an update on activities with Avion Pharmaceuticals LLC following the successful licence and development agreement signed with Avion in November 2019 for the

    Immupharma Plc

    What is Lupus?

    Lupus is an autoimmune disease; there are two types of lupus, discoid lupus erythematosus and systemic lupus erythematosus.  For today I will mainly discuss systemic lupus. Just like I explained in my previous column, an autoimmune

    Immupharma Plc

    What to know about Lupus, the disease of 1,000 faces

    Lupus, also known as the disease of 1,000 faces due to its complex features comes with different signs and symptoms that involve the joints, skin, kidneys, blood cells, brain, heart and lungs. It is a lifelong

    Immupharma Plc

    Selena Gomez opens up about her battle against lupus

    Selena Gomez has opened up about her intense time in hospital when she thought she might “actually die” from kidney failure in a wide-ranging interview with the Wall Street Journal. The 27-year-old former Disney star was interviewed by social media

    Immupharma Plc

    Signs of Lupus in Women

    Anyone can have lupus, but the fact is that women have more than their fair share of this autoimmune condition. In the U.S., an estimated 1 million to 1.5 million people have lupus, and women account for about

    Immupharma Plc

    Lupuzor™ The Wonder Drug From ImmuPharma Plc

    ImmuPharma (LON: IMM) is a United Kingdom domiciled clinical stage therapeutics and Biotechnology company that has interests in the Research and development of novel therapeutics compounds as well as manufacturing of various drugs based on these

    Immupharma Plc

    ImmuPharma will today commence trading on Euronext Growth Brussels

    ImmuPharma (LON:IMM | Euronext Growth: ALIMM), a specialist drug discovery and development company, has today announced that, this morning at approximately 09.00am (GMT), ImmuPharma will commence trading on Euronext Growth Brussels under ticker ‘ALIMM’. This new listing does

    Immupharma Plc

    ImmuPharma to be admitted on Euronext Growth Brussels

    ImmuPharma (LON:IMM), a specialist drug discovery and development company, has today announced that its shares will be admitted to trading on Euronext Growth Brussels under ticker ‘ALIMM’ following the approval by Euronext of its request for